Europe Metagenomics Market Size & Outlook, 2023-2030
Europe metagenomics market, 2018-2030 (US$M)
Related Markets
Europe metagenomics market highlights
- The Europe metagenomics market generated a revenue of USD 586.7 million in 2023.
- The market is expected to grow at a CAGR of 13.1% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 586.7 million |
| Market revenue in 2030 | USD 1,388.7 million |
| Growth rate | 13.1% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.9% of the global metagenomics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 938.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe metagenomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to metagenomics market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 61.48% in 2023. Horizon Databook has segmented the Europe metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
The UK metagenomics market is expected to grow in tandem with the overall European market owing to increasing development of companion diagnostics and subsequent establishment of molecular diagnostic development facilities by key market players. Furthermore, ongoing strategic alliances between players in European and eastern markets are expected to fuel the region’s metagenomics market during the forecast period.
Consequently, the UK follows Germany, and with the expected implementation of nationwide Europe WGS projects in the coming years, the UK metagenomics market is expected to witness substantial growth in the coming years. In 2018, the 1+ Million Genomes initiative was initiated to improve disease prevention, enable more individualized treatments, and fund groundbreaking research. This initiative aims to allow secure access to genomics and related clinical data across European countries for personalized healthcare, better research, and health policymaking.
Reasons to subscribe to Europe metagenomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe metagenomics market databook
-
Our clientele includes a mix of metagenomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe metagenomics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe metagenomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe metagenomics market size, by country, 2018-2030 (US$M)
Europe Metagenomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
